The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...
Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...
The Biden administration is reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity ...
The Biden administration on Tuesday proposed that weight-loss drugs be paid for by Medicaid and Medicare, potentially making ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...
Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...
By Evan Bush The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for ...
Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration ...
As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback